Baker Bros Advisors LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Baker Bros Advisors LP
CRD #158149
SEC #801-73446
CIK #0001263508
AUM $23.2 BB (2023-03-24)
Employees 50 (28% Investors, 0% Brokers)
Phone212-339-5600
Address860 Washington Street, 3rd Floor
New York, NY 10014
Source [IAPD] [EDGAR]
Total AUM ($BB)
40322416802010201420192024
Sector Form 13F Holdings Cap ($BB) Value ($BB)
SGEN 32.9 9.5
INCY 16.8 2.6
BGNE 17.0 2.5
ACAD 2.3 0.8
MDGL 1.2 0.4
BMRN 15.4 0.4
IMCR 1.6 0.1
RYTM 0.2 0.1
KOD 0.4 0.1
BCRX 1.9 0.1
View All
Holdings by Sector ($BB)
30241812602011201520192024
Type Form D Funds Date Sold ($MM) AUM ($MM)
HF 14159 LP 2012-02-13 17.0
HF 667 LP 2012-02-13 1,853.5
HF Baker Biotech Fund II A LP 2012-02-13 9.4
HF Baker Bros Investments II LP 2012-02-13 1.2
HF Baker Bros Investments LP 2012-02-13 9.8
HF Baker Brothers Life Sciences LP [2012-02-13] 0.0 21,301.0
HF Baker/Tisch Investments LP 2012-02-13 11.0
AUM Breakdown Accounts AUM ($BB)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 2 23.2
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 2 23.2
By Discretionary
Discretionary 2 23.2
Non-Discretionary 0 0.0
Total 2 23.2
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 23.2
Total 2 23.2
Form D Directors # Filings # Firms 2011 - 2024
General Partner Baker Brothers Life Sciences Capital LP 12
EDGAR Form CIK 2011 - 2024
13F-HR [0001263508]
3 [0001263508]
4 [0001263508]
5 [0001263508]
SC 13D [0001263508]
SC 13G [0001263508]
Form 13D/13G Filer Form 13D/13G Subject Filed
Baker Bros Advisors LP Bellicum Pharmaceuticals Inc [2023-05-05]
Baker Bros Advisors LP Cyteir Therapeutics Inc [2023-02-14]
Baker Bros Advisors LP Replimune Group Inc [2023-02-14]
Baker Bros Advisors LP Inozyme Pharma Inc [2023-02-14]
Baker Bros Advisors LP Kymera Therapeutics Inc [2023-02-14]
Baker Bros Advisors LP Hookipa Pharma Inc [2023-02-14]
Baker Bros Advisors LP Kala Pharmaceuticals Inc [2023-02-14]
Baker Bros Advisors LP 2Seventy Bio Inc [2023-02-14]
Baker Bros Advisors LP Biomea Fusion Inc [2023-02-14]
Baker Bros Advisors LP Aravive Inc [2023-02-14]
View All
Form 3/4/5 Subject 2011 - 2024
Baker Julian
Baker Bros Advisors LP
667 LP
Baker Felix
Baker Bros. Advisors (GP) LLC
Talis Biomedical Corp
Baker Brothers Life Sciences LP
Neoleukin Therapeutics, Inc.
Kiniksa Pharmaceuticals, Ltd.
Acadia Pharmaceuticals Inc
View All
Comparable Firms State AUM ($BB)
Towers Watson Investment Management Limited
24.8
Parallax Volatility Advisers LP
CA 24.6
Vontobel Asset Management Inc
NY 24.1
D E Shaw Investment Management LLC
NY 24.1
Veritas Asset Management LLP
23.5
Rafferty Asset Management LLC
NY 23.1
Franklin Templeton Investment Management Limited
22.9
Pictet Asset Management Limited
22.0
Sound Point Capital Management LP
NY 21.6
Pacific Asset Management LLC
CA 20.2
Terms | Privacy | Guide
tony@aum13f.com